Table 2.

Area Under The Receiver Operating Curve (AUROC) describing the performance of Non-invasive fibrosis predictive models in chronic viral hepatitis B, C and D

Advanced Fibrosis AUROC by Virus (Ishak Fibrosis Score ≥4)
Model	HDV	HBV	HCV
	Area (Confidence Interval)
logFib4	0.70 (0.55–0.84)	0.81 (0.75–0.87)	0.86 (0.83–0.89)
logAPRI	0.68 (0.54–0.82)	0.73 (0.65–0.80)	0.84 (0.81–0.88)
logAAR	0.63 (0.48–0.77)	0.71 (0.63–0.79)	0.71 (0.58–0.68)
logAPI	0.69 (0.55–0.89)	0.78 (0.72–0.84)	0.80 (0.76–0.84)
logHui	0.63 (0.49–0.78)	0.77 (0.70–0.84)	0.81 (0.78–0.85)
Cirrhosis AUROC by Virus (Ishak Fibrosis Score =6)
	Area (Confidence Interval)
logFib4	0.83 (0.69–0.97)	0.83 (0.75–0.91)	0.91 (0.87–0.95)
logAPRI	0.75 (0.61–0.89)	0.69 (0.55–0.82)	0.87 (0.83–0.92)
logAAR	0.70 (0.48–0.93)	0.78 (0.69–0.86)	0.68 (0.61–0.76)
logAPI	0.80 (0.66–0.95)	0.80 (0.71–0.89)	0.88 (0.83–0.93)
logHui	0.70 (0.49–0.91)	0.77 (0.65–0.89)	0.83 (0.76–0.89)